Jeffrey Lee Romine

This inventor holds 34 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 21 EPO patents, primarily in HCV Inhibitors. Top assignee: Bristol-Myers Squibb Compnay. Active years: 1993-2021.

USPTO Granted Patents = 34 (Patent Applications = 6)

% Patents Active = 91.2

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 21 (Patent Applications = 22)

Average Co-Inventor Count = 6.9

ph-index = 14

Forward Citations = 536(Granted Patents)

Company Filing History:

34 out of 3,736

Bristol-Myers Squibb Compnay

patents

Years Active: 1993-2021

Loading Chart...

Areas of Expertise:

HCV Inhibitors

Immunomodulators

Potassium Channel Modulators

Isoquinoline Derivatives

Hepatitis C

Human Immunodeficiency Virus

Platelet Aggregation

Cycloalkyl Heterocycles

Diphenyl Imidazoles

Diphenyl Triazoles

Diphenyl Oxadiazolones

Iminothiazolidinones

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11046675 - Substituted isoquionline derivatives as immunomudulators (2021-06-29),

2. 9758487 - Hepatitis C virus inhibitors (2017-09-12),

3. 9561212 - Hepatitis C virus inhibitors (2017-02-07),

4. 9227961 - Hepatitis C virus inhibitors (2016-01-05),

5. 9193720 - Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication (2015-11-24),

6. 9018390 - Hepatitis C virus inhibitors (2015-04-28),

7. 8846023 - Hepatitis C virus inhibitors (2014-09-30),

8. 8809548 - Hepatitis C virus inhibitors (2014-08-19),

9. 8796466 - Hepatitis C virus inhibitors (2014-08-05),

10. 8735398 - Hepatitis C virus inhibitors (2014-05-27),

11. 8642025 - Hepatitis C virus inhibitors (2014-02-04),

12. 8574563 - Hepatitis C virus inhibitors (2013-11-05),

13. 8492553 - Hepatitis C virus inhibitors (2013-07-23),

14. 8394968 - Hepatitis C virus inhibitors (2013-03-12),

15. 8377980 - Hepatitis C virus inhibitors (2013-02-19),

Title: Jeffrey Lee Romine: Pioneering Innovations in Technology

Introduction:

Jeffrey Lee Romine, a visionary inventor hailing from Meriden, CT, is a shining example of unwavering dedication to innovation in the realm of technology. With a portfolio comprising 34 patents, Romine's groundbreaking work is setting the stage for the future of technology.

Latest Patents:

1. Substituted isoquinoline derivatives as immunomodulators: Romine's latest patent showcases his expertise in developing compounds that serve as potent immunomodulators. These compounds hold promise in the treatment of various diseases, including cancer and infectious diseases.

2. Hepatitis C virus inhibitors: Another recent patent by Romine focuses on compounds and compositions designed for combating Hepatitis C virus (HCV) infection. These pharmaceutical compositions offer a new frontier in the treatment of HCV.

Career Highlights:

Currently affiliated with Bristol-Myers Squibb Company, Romine's innovative spirit finds the perfect nurturing ground in this esteemed organization. Through his tenure, he has spearheaded numerous projects that have pushed the boundaries of technological advancement.

Collaborations:

At Bristol-Myers Squibb Company, Romine collaborates closely with accomplished individuals such as Denis R St Laurent and Nicholas A Meanwell. This collaborative environment fosters creativity and propels the team towards impactful discoveries.

Conclusion:

Jeffrey Lee Romine's trailblazing journey in the world of invention stands as a testament to his passion for driving positive change through innovation. With an impressive array of patents and a steadfast commitment to excellence, Romine continues to shape the landscape of technology, inspiring generations to come.